May reduce cell damage from alcoholic & non-alcoholic fatty liver disease Glutathione is being looked at in clinical studies for use in the treatment of fatty liver disease
If the gene is expressing very early in life, its easy to spot
The one human trial that will measure tolerability directly has not started reporting it is only recruiting (planned 2026), studies a topical gel on small standardized wounds , and lists safety as a secondary, not primary, outcome (NCT07437586)
Physio helped but it never properly resolved
Its not hard to understand why sticking with this regime is challenging a large minority of patients report unpleasant side effects such as nausea and vomiting, and some experience additional side effects such as injection-site reactions, infections, heart burn, and headaches
LLLT works through a completely different mechanism than PTD-DBM and can be used simultaneously without interference